A cross-disorder method to identify novel candidate genes for developmental brain disorders

JAMA Psychiatry

Volumn 73, Issue 3, 2016, Pages 275-283

  Gonzalez Mantilla, Andrea J ^a   Moreno De Luca, Andres ^a   Ledbetter, David H ^a   Martin, Christa Lese ^a  

^a GEISINGER HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ATTENTION DEFICIT DISORDER; AUTISM; BIPOLAR DISORDER; BRAIN DISEASE; CHROMOSOME ANALYSIS; CLINICAL EVALUATION; DEVELOPMENTAL BRAIN DISORDER; EPILEPSY; EXOME; GENE; GENE FREQUENCY; GENE SEQUENCE; GENE TARGETING; GENETIC IDENTIFICATION; GENETIC RISK; GENETIC VARIABILITY; GENOME; HUMAN; INHERITANCE; INTELLECTUAL IMPAIRMENT; LOSS OF FUNCTION MUTATION; MENTAL DISEASE; MICROARRAY ANALYSIS; PHENOTYPE; REVIEW; SCHIZOPHRENIA; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; BRAIN DISEASES; DEVELOPMENTAL DISABILITIES; GENETIC PREDISPOSITION; GENETICS; GENOMICS; HUMAN GENOME;

ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; BIPOLAR DISORDER; BRAIN DISEASES; DEVELOPMENTAL DISABILITIES; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOMICS; HUMANS; PHENOTYPE;

EID: 84962504597     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2015.2692     Document Type: Review

References (31)

1. Moreno-De-Luca A, Myers SM, Challman TD, Moreno-De-Luca D, Evans DW, Ledbetter DH. Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence. Lancet Neurol. 2013;12(4):406-414.
2. Reiss AL. Childhood developmental disorders: an academic and clinical convergence point for psychiatry, neurology, psychology and pediatrics. J Child Psychol Psychiatry. 2009;50(1-2):87-98.
3. Yeargin-Allsopp M, Boyle C, van Naarden-Braun K, Trevathan E. The epidemiology of developmental disabilities. In: Accardo PJ, ed. Capute and Accardo's Neurodevelopmental Disabilities in Infancy and Childhood. Vol I. Neurodevelopmental Diagnosis and Treatment. 3rd ed. Baltimore, MD: Paul H. Brookes Publishing Co; 2008:61-104.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
5. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, Switzerland:World Health Organization; 2010.
6. Martin J, Cooper M, HamshereML, et al. Biological overlap of attention-deficit/hyperactivity disorder and autism spectrum disorder: evidence from copy number variants. J AmAcad Child Adolesc Psychiatry. 2014;53(7):761-70.e26, e726.
7. McCarthy SE, Gillis J, Kramer M, et al. De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability. Mol Psychiatry. 2014;19(6):652-658.
8. Moreno-De-Luca D, Moreno-De-Luca A, Cubells JF, Sanders SJ. Cross-disorder comparison of four neuropsychiatric CNV loci. Curr Genet Med Rep. 2014;2(3):151-161.
9. Béna F, Bruno DL, Eriksson M, et al. Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature. Am J Med Genet B Neuropsychiatr Genet. 2013;162B(4):388-403.
10. Helsmoortel C, Vulto-van Silfhout AT, Coe BP, et al. A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP. Nat Genet. 2014;46 (4):380-384.
11. Bernier R, Golzio C, Xiong B, et al. Disruptive CHD8 mutations define a subtype of autism early in development. Cell. 2014;158(2):263-276.
12. Kim YS, StateMW. Recent challenges to the psychiatric diagnostic nosology: a focus on the genetics and genomics of neurodevelopmental disorders. Int J Epidemiol. 2014;43(2):465-475.
13. Chaudhry A, Noor A, Degagne B, et al; DDD Study. Phenotypic spectrum associated with PTCHD1 deletions and truncating mutations includes intellectual disability and autism spectrum disorder. Clin Genet. 2015;88(3):224-233.
14. Cancrini C, Puliafito P, Digilio MC, et al; Italian Network for Primary Immunodeficiencies. Clinical features and follow-up in patients with 22q11.2 deletion syndrome. J Pediatr. 2014;164(6):1475-80.e2, e1472.
15. Moreno-De-Luca A, Evans DW, Boomer KB, et al. The role of parental cognitive, behavioral, and motor profiles in clinical variability in individuals with chromosome 16p11.2 deletions. JAMA Psychiatry. 2015;72(2):119-126.
16. Haldeman-Englert C, Jewett T. 1q21.1 microdeletion. In: Pagon RA, Adam MP, Ardinger HH, et al, eds. GeneReviews(R). Seattle: University ofWashington; 1993.
17. Moreno-De-Luca D, Mulle JG, Kaminsky EB, et al; SGENE Consortium; Simons Simplex Collection Genetics Consortium; GeneSTAR. Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am J Hum Genet. 2010;87(5):618-630.
18. Need AC, Shashi V, Hitomi Y, et al. Clinical application of exome sequencing in undiagnosed genetic conditions. J Med Genet. 2012;49(6):353-361.
19. Yang Y, Muzny DM, Xia F, et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA. 2014;312(18): 1870-1879.
20. Lee H, Deignan JL, Dorrani N, et al. Clinical exome sequencing for genetic identification of rare mendelian disorders. JAMA. 2014;312(18):1880-1887.
21. Srivastava S, Cohen JS, Vernon H, et al. Clinical whole exome sequencing in child neurology practice. Ann Neurol. 2014;76(4):473-483.
22. De Rubeis S, He X, Goldberg AP, et al; DDD Study; Homozygosity Mapping Collaborative for Autism; UK10K Consortium. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature. 2014;515(7526):209-215.
23. Purcell SM, Moran JL, Fromer M, et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature. 2014;506(7487):185-190.
24. Deciphering Developmental Disorders S; Deciphering Developmental Disorders Study. Large-scale discovery of novel genetic causes of developmental disorders. Nature. 2015;519(7542): 223-228.
25. Sanders SJ, MurthaMT, Gupta AR, et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature. 2012;485(7397):237-241.
26. Willsey AJ, Sanders SJ, Li M, et al. Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell. 2013;155(5):997-1007.
27. Dong S,WalkerMF, Carriero NJ, et al. De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder. Cell Rep. 2014;9(1):16-23.
28. Iossifov I, O'Roak BJ, Sanders SJ, et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature. 2014;515(7526):216-221.
29. EuroEPINOMICS-RES Consortium; Epilepsy Phenome/Genome Project; Epi4K Consortium. De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. Am J Hum Genet. 2014;95(4):360-370.
30. Beck TN, Nicolas E, Kopp MC, Golemis EA. Adaptors for disorders of the brain? the cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer's disease. Oncoscience. 2014;1(7):486-503.
31. Li J, Cai T, Jiang Y, et al. Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database [published onlineMay 5, 2015]. Mol Psychiatry. doi: 10.1038/mp.2015.58.